Januvia
Novo’s oral semaglutide beats Victoza and Januvia in diabetes
June 21, 2018Research and Development Januvia, MSD, Novo Nordisk, Victoza, pharma, semaglutide
Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …
Merck diabetes drug gets CV trial boost
June 9, 2015Research and Development, Sales and Marketing Januvia, Merck, cv, diabetes, sitagliptin
Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …
Sales forecasts leave Sovaldi top and Januvia lagging
May 23, 2014Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi
Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …
MSD takes Januvia rap
July 9, 2013Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA
Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …
Diabetes prescriptions jump by 50% in England
August 15, 2012Sales and Marketing Humalog, Januvia, NHS, diabetes, spending
Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …
FDA approves greener process for Januvia production
May 1, 2012Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing
The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …
Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
Victoza superiority to Januvia made official by FDA
April 10, 2012Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes
Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …
Merck warned over missing Januvia safety study
March 13, 2012Research and Development FDA, Januvia, Merck, study
Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …
US approval for Merck’s Januvia-Zocor combination
October 10, 2011Sales and Marketing Januvia, Juvisync, Zocor
US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …
Fresh scrutiny for new diabetes drugs
September 15, 2011Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes
Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …
Januvia helps stabilise Merck sales
October 23, 2009Sales and Marketing Januvia, Merck
Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …
Januvia launched in UK
April 25, 2007Sales and Marketing Januvia, diabetes
Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …
